The company's stock has climbed by 31.22% in the past month, exceeding the Medical sector's gain of 0.61% and the S&P 500's gain of 2.73%. The investment community will be closely monitoring the performance of Hims & Hers Health, Inc. in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.05, marking a 266.67% rise compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $297.53 million, up 43.1 ...